Alpha Teknova, Inc. Common Stock (TKNO) Stock Price

TKNOStock

$7.46+54.53%52W

Market Cap$400.51M

P/E—

PEG Ratio—

Div yield—

Beta0.87

TKNO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)250.33%

Price vs S&P 500 (4W)41.15%

VGM Score58.79

Book Value / Share (Quarterly)$1.21

P/TBV (Annual)3.58x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-0.73%

Cash Flow / Share (Quarterly)$-0.17

Price vs S&P 500 (YTD)81.20%

Gross Margin (TTM)34.01%

Net Profit Margin (TTM)-41.07%

EPS (TTM)$-0.32

10-Day Avg Trading Volume0.41M

EPS Excl Extra (TTM)$-0.32

Revenue Growth (5Y)5.30%

EPS (Annual)$-0.32

ROI (Annual)-21.07%

Gross Margin (Annual)33.17%

Net Profit Margin (5Y Avg)-70.98%

Cash / Share (Quarterly)$0.33

Revenue Growth QoQ (YoY)13.09%

ROA (Last FY)-16.66%

Revenue Growth TTM (YoY)9.29%

EBITD / Share (TTM)$-0.28

ROE (5Y Avg)-30.55%

Operating Margin (TTM)-39.02%

Cash Flow / Share (Annual)$-0.18

P/B Ratio6.10x

P/B Ratio (Quarterly)2.39x

Net Income / Employee (Annual)$-109,200

EV / Revenue (TTM)9.69x

Net Interest Coverage (TTM)-23.23x

ROA (TTM)-16.34%

EPS Incl Extra (Annual)$-0.32

Current Ratio (Annual)4.58x

Quick Ratio (Quarterly)3.40x

3-Month Avg Trading Volume0.18M

52-Week Price Return54.53%

Revenue / Employee (TTM)$264,600

Tangible BV / Share (Quarterly)$0.99

P/S Ratio (Annual)9.78x

Asset Turnover (Annual)0.39x

52-Week High$7.84

Operating Margin (5Y Avg)-72.56%

EPS Excl Extra (Annual)$-0.32

CapEx CAGR (5Y)-26.82%

26-Week Price Return261.58%

Quick Ratio (Annual)3.44x

13-Week Price Return89.66%

Total Debt / Equity (Annual)0.19x

Current Ratio (Quarterly)4.59x

Enterprise Value$405.08M

Revenue / Share Growth (5Y)-8.08%

Asset Turnover (TTM)0.40x

Revenue / Employee (Annual)$256,500

Inventory Turnover (Annual)3.91x

Pretax Margin (Annual)-42.45%

Cash / Share (Annual)$0.40

3-Month Return Std Dev84.81%

Gross Margin (5Y Avg)34.07%

Net Income / Employee (TTM)$-108,700

ROE (Last FY)-25.09%

Net Interest Coverage (Annual)-20.77x

EPS Basic Excl Extra (Annual)$-0.32

Receivables Turnover (TTM)7.41x

Total Debt / Equity (Quarterly)0.20x

EPS Incl Extra (TTM)$-0.32

Receivables Turnover (Annual)9.07x

ROI (TTM)-20.51%

P/S Ratio (TTM)9.48x

Pretax Margin (5Y Avg)-73.62%

Revenue / Share (Annual)$0.76

Tangible BV / Share (Annual)$1.06

Price vs S&P 500 (52W)36.22%

Year-to-Date Return93.16%

5-Day Price Return7.78%

EPS Normalized (Annual)$-0.32

ROA (5Y Avg)-20.97%

Net Profit Margin (Annual)-42.59%

Month-to-Date Return46.80%

Cash Flow / Share (TTM)$-1.21

EBITD / Share (Annual)$-0.30

Operating Margin (Annual)-41.90%

LT Debt / Equity (Annual)0.19x

ROI (5Y Avg)-25.97%

LT Debt / Equity (Quarterly)0.20x

EPS Basic Excl Extra (TTM)$-0.32

P/TBV (Quarterly)2.91x

P/B Ratio (Annual)2.96x

Inventory Turnover (TTM)4.10x

Pretax Margin (TTM)-40.87%

Book Value / Share (Annual)$1.28

Price vs S&P 500 (13W)86.87%

Beta0.87x

Revenue / Share (TTM)$0.78

ROE (TTM)-24.32%

52-Week Low$1.91

vGradeD

gGradeC

mGradeA

vgmGradeC

TKNO Earnings Surprise History

Q2 25-0.07est. -0.10

Q3 25-0.08est. -0.09

Q4 25-0.09est. -0.09

Q1 26-0.08est. -0.09

Q2 26-0.05est. -0.07

TKNO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.08

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
TKNOAlpha Teknova, Inc. Common Stock	D	C	A	$7.46
IDXXIdexx Laboratories Inc	D	B	C	$550.01
LNTHLantheus Holdings, Inc	C	B	B	$100.87
CLDXCelldex Therapeutics, Inc	F	F	B	$41.22
NEOGNeogen Corp	C	C	B	$11.64
NTLAIntellia Therapeutics, Inc	D	D	C	$13.51
QDELQuidelOrtho Corporation Common Stock	C	C	C	$15.05
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.17
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.83
MYGNMyriad Genetics Inc	B	C	D	$3.19
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.44
ICCCImmucell Corp	C	B	B	$9.84
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.44
TRIBTrinity Biotech plc	B	D	F	$9.71
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	B	$1.91
BMRABIOMERICA INC	B	D	D	$1.77
VNRXVolitionRx Limited	B	A	F	$0.38
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	D	$2.91
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	C	$0.01

About Alpha Teknova, Inc. Common Stock

Alpha Teknova Inc manufactures critical reagents used in the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers two primary product lines—Lab Essentials and Clinical Solutions—comprised of pre-poured culture media plates, liquid microbial media, and molecular biology reagents for sample preparation and purification. Primary revenue is generated from the United States market.